Ventana med sys inc received replacement instrument parts back for analysis.A rep retained sample of cytokeratin 5/6 was used.The parts and the regent kit are performing as labeled.Investigation will conclude in the next few days.No failure mode has been identified.The regent kit the customer was using has not been returned for evaluation.Pt is on corret therapy according to the customer, and adverse effects have been reported to the mfr.Returned part evaluation shows no instrument-related contribution to the negative result at this time.Roche service organization will encourage the customer to conduct timely pre-checks of all necessary parameters before running.The customer is reported to be running normally now.The pt is reported to be on correct therapy.
|